Many clinical trials today are still using paper to collect data. Over this 5-part blog series, we’ll examine some of the common challenges with data collection during oncology trials today and explore how you can overcome these challenges. Check back soon to read the next blog in this 5-part series!
Site challenges in oncology clinical trials and eCOA benefits
The majority of oncology trials are still completed through site visits which are increasingly admin-heavy as the number of tasks in study protocols continues to grow. This blog post examines the challenges that sites are up against when using paper, and how Electronic Clinical Outcome Assessments (eCOA) can help reduce or eliminate these challenges.
Let's look at the most common site challenges, and how they can be resolved with eCOA:
eCOA: A solution that works
According to the American Society of Clinical Oncology (ASCO), “In multiple prospective studies, integrating ePROs into routine cancer care has improved patient-clinician communication, patient satisfaction, symptom management and control, and quality of life. Nurses find symptom email alerts to be useful and actionable. Recent data have found reductions in emergency room visits, longer tolerability of chemotherapy, and improved survival. This evidence of benefits has led to growing interest in this approach.”
The advantages of using electronic data collection methods during oncology clinical trials are very clear, with industry leaders becoming the first to adopt this approach, much like when the industry switched from paper to electronic health records.
Like this blog post? You may also be interested in:
- eBook: Reducing the Burden of Data Collection in Oncology Trials
- Video: Can Seniors Use Electronic Clinical Outcome Assessments (eCOA)?
About the Author